메뉴 건너뛰기




Volumn 29, Issue 50, 2011, Pages 9290-9291

Limited benefit of HPV vaccination for sexually active women in developing countries

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

EID: 80855132843     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.108     Document Type: Letter
Times cited : (2)

References (6)
  • 1
    • 78649661080 scopus 로고    scopus 로고
    • Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine
    • Monsonego J., Cortes J., Greppe C., Hampl M., Joura E., Singer A. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine. Vaccine 2010, 28(51):8065-8072.
    • (2010) Vaccine , vol.28 , Issue.51 , pp. 8065-8072
    • Monsonego, J.1    Cortes, J.2    Greppe, C.3    Hampl, M.4    Joura, E.5    Singer, A.6
  • 3
    • 34248326338 scopus 로고    scopus 로고
    • Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
    • The FUTURE II Study Group
    • Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. New Engl J Med 2007, 356(19):1915-1927. The FUTURE II Study Group.
    • (2007) New Engl J Med , vol.356 , Issue.19 , pp. 1915-1927
  • 4
    • 77749279739 scopus 로고    scopus 로고
    • Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women
    • Muñoz N., Kjaer S.K., Sigurdsson K., Iversen O.E., Hernandez-Avila M., Wheeler C.M., et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst 2010, 102(5):325-339.
    • (2010) J Natl Cancer Inst , vol.102 , Issue.5 , pp. 325-339
    • Muñoz, N.1    Kjaer, S.K.2    Sigurdsson, K.3    Iversen, O.E.4    Hernandez-Avila, M.5    Wheeler, C.M.6
  • 5
    • 79952363148 scopus 로고    scopus 로고
    • Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States
    • Grant L.A., Dunne E.F., Chesson H., Markowitz L.E. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States. Vaccine 2011, 29(13):2365-2370.
    • (2011) Vaccine , vol.29 , Issue.13 , pp. 2365-2370
    • Grant, L.A.1    Dunne, E.F.2    Chesson, H.3    Markowitz, L.E.4
  • 6
    • 64149131410 scopus 로고    scopus 로고
    • Human papillomavirus vaccines: WHO position paper
    • Available from: World Health Organization (WHO)
    • World Health Organization (WHO) Human papillomavirus vaccines: WHO position paper. Wkly Epidemiol Rec 2009, 84(15):118-131. Available from: http://www.who.int/wer/2009/wer8415.pdf.http://www.who.int/wer/2009/wer8415/en/index.html.
    • (2009) Wkly Epidemiol Rec , vol.84 , Issue.15 , pp. 118-131


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.